Jacqueline P. Ernest

MedicineComputer ScienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant Tuberculosis”.

Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant Tuberculosis

The Annual Review of Pharmacology and Toxicology(2020)10.1146/annurev-pharmtox-030920-011143

N/A

0DataRank · unranked

48 citations

Natasha Strydom, Qianwen Wang, Nan Zhang, Eric L. Nuermberger, Véronique Dartois +2 more

Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary Tuberculosis

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.00506-21

N/A

0DataRank · unranked

34 citations

Jansy P. Sarathy, Ning Wang, Firat Kaya, Matthew Zimmerman, Natasha Strydom +9 more

Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.01705-21

N/A

0DataRank · unranked

6 citations

Jacqueline P. Ernest, Nan Zhang, Nicole C. Ammerman, Eric L. Nuermberger, Robert Belknap +4 more

A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case Study

Antimicrobial Agents and Chemotherapy(2022)10.1128/aac.02212-21

N/A

0DataRank · unranked

21 citations

Jacqueline P. Ernest, Katherine LoMauro, Martin Gengenbacher, Abdeldjalil Madani, Wassihun Wedajo Aragaw +15 more

Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs

European Respiratory Journal(2023)10.1183/13993003.00165-2023

N/A

0DataRank · unranked

16 citations

Janice Jia Ni Goh, Natasha Strydom, Qianwen Wang, Rob C. van Wijk, Nan Zhang +4 more

Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.18.524608

N/A

0DataRank · unranked

2 citations

Janice Jia Ni Goh, Natasha Strydom, Qianwen Wang, Rob C. van Wijk, Nan Zhang +4 more

The Kinetics of Bedaquiline Diffusion in Tuberculous Cavities Open a Window for the Emergence of Resistance

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf303

N/A

0DataRank · unranked

6 citations

Jacqueline P. Ernest, Firat Kaya, Connie Silva, Jansy P. Sarathy, Landry Blanc +11 more

Translational Modeling of BTZ-043 to Predict Phase 2A Efficacy and Evaluate Drug-Drug Interactions With Bedaquiline, Pretomanid, and Linezolid in Murine Models

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf088

N/A

0DataRank · unranked

1 citations

Lorenzo Flori, Rob C. van Wijk, Jacqueline P. Ernest, Sandeep Tyagi, Heena Soni +7 more

Lesion penetration predicts tuberculosis regimen success: a validated translational tool for de-risking late-stage drug development

Research Square(2025)10.21203/rs.3.rs-6890010/v1

N/A

0DataRank · unranked

0 citations

Jacqueline P. Ernest, Annamarie E. Bustion, Anu Patel, Jansy P. Sarathy, Firat Kaya +9 more